Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Restricted kappa/lambda light chain ratio by flow cytometry in germinal center B cells in Hashimoto thyroiditis.Am J Clin Pathol. 2006; 125: 42-48
- The diagnostic value of kappa/lambda ratios determined by flow cytometric analysis of biopsy specimens in B-cell lymphoma.Clin Lab Haematol. 2002; 24: 33-36
- Comparative analysis of light chain expression in germinal center cells and mantle cells of reactive lymphoid tissues. A four-color flow cytometric study.Am J Clin Pathol. 2003; 119: 130-136
- Quantitative criteria for clonality in the diagnosis of B-cell non- Hodgkin's lymphoma by flow cytometry.Mod Pathol. 1993; 6: 155-161
- Results of multiparameter studies of B-cell lymphomas.Am J Clin Pathol. 1979; 72: 687-698
- Abnormal patterns of antigenic expression in follicular lymphoma: a flow cytometric study.Am J Clin Pathol. 2005; 124: 576-583
- Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.Am J Clin Pathol. 2005; 123: 826-832
- Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.Leukemia. 2002; 16: 1460-1469
- Diminished expression of CD19 in B-cell lymphomas.Cytometry B Clin Cytom. 2005; 63: 28-35
- Flow cytometry in the assessment of hematologic disorders.in: Orazi A. Foucar K. Knowles D.M. Neoplastic hematopathology. Lippincott, Williams and Wilkins, Baltimore (MD)2013: 119-145
- Prominent clonal B cell populations identified by flow cytometry in histologically-reactive lymphoid proliferations.Am J Clin Pathol. 2004; 121: 464-472
- Monoclones, monotypes, and neoplasia pitfalls in lymphoma diagnosis.Am J Clin Pathol. 2004; 121: 457-459
- Expanded populations of surface membrane immunoglobulin light chain-negative B cells in lymph nodes are not always indicative of B-cell lymphoma.Am J Clin Pathol. 2005; 124: 143-150
- Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma.Am J Clin Pathol. 2002; 118: 229-234
- Flow cytometric analysis of surface light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies.Am J Clin Pathol. 2011; 136: 954-959
- Anaplastic large cell lymphoma: a flow cytometric analysis of 29 cases.Am J Clin Pathol. 2007; 128: 314-322
- Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study.Am J Clin Pathol. 2002; 117: 291-300
- The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.Leukemia. 1994; 8: 1640-1645
- Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.Am J Hematol. 1992; 40: 259-263
- Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).Am J Clin Pathol. 1997; 108: 378-382
- CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.Haematologica. 2010; 95: 604-612
- CD5+ low-grade marginal zone B-cell lymphomas with localized presentation.Am J Surg Pathol. 1998; 22: 201-207
- CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.Am J Clin Pathol. 1996; 105: 31-37
- CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.Cytometry B Clin Cytom. 2010; 78: S35-S41
- Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom's macroglobulinemia.Mod Pathol. 2009; 22: 807-816
- CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases.Mod Pathol. 2015; 28: 787-798
- CD5 positive hairy cell leukemia: a rare case report with brief review of literature.Cytometry B Clin Cytom. 2016; 90: 467-472
- Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia.Am J Clin Pathol. 2005; 124: 414-420
- B-cell lymphomas with coexpression of CD5 and CD10.Am J Clin Pathol. 2003; 119: 218-230
- The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma.Am J Clin Pathol. 1996; 105: 451-457
- Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody.Am J Clin Pathol. 1994; 101: 283-289
- Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas.Blood. 1994; 83: 1626-1631
- Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.Am J Clin Pathol. 1993; 100: 373-385
- Mantle cell lymphoma: a clinicopathologic study of 80 cases.Blood. 1997; 89: 2067-2078
- CD5-positive B-cell neoplasms of indeterminate immunophenotype: a clinicopathologic analysis of 26 cases.Appl Immunohistochem Mol Morphol. 2005; 13: 311-317
- CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases.Am J Clin Pathol. 2003; 120: 760-766
- Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23.Mod Pathol. 1994; 7: 326-331
- Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.Am J Clin Pathol. 2001; 116: 893-897
- CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.Leuk Res. 2009; 33: 1212-1216
- CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease.Am J Clin Pathol. 2008; 130: 166-177
- Immunophenotypic variations in mantle cell lymphoma.Am J Clin Pathol. 2009; 132: 699-706
- Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging.Am J Clin Pathol. 2014; 142: 837-844
- CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.Cytometry B Clin Cytom. 2014; 86: 98-105
- Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma.Am J Clin Pathol. 2012; 137: 93-100
- Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.Leuk Lymphoma. 2015; 56: 3329-3335
- Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.Arch Pathol Lab Med. 2014; 138: 903-909
- The role of CD11c expression in the diagnosis of mantle cell lymphoma.Am J Clin Pathol. 2010; 134: 271-277
- BRAF mutations in hairy-cell leukemia.N Engl J Med. 2011; 364: 2305-2315
- Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.Blood. 2012; 119: 192-195
- The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.Blood. 2012; 119: 188-191
- Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.Br J Haematol. 2009; 145: 733-740
- Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.Blood. 1993; 82: 1277-1287
- Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.Am J Clin Pathol. 2011; 136: 625-630
- The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.Haematologica. 2004; 89: 303-308
- CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders.Am J Clin Pathol. 2013; 140: 536-543
- The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.Leuk Lymphoma. 1994; 14: 57-61
- Immunophenotypic variations in hairy cell leukemia.Am J Clin Pathol. 2006; 125: 251-259
- Analysis of CD10+ hairy cell leukemia.Am J Clin Pathol. 2003; 120: 228-235
- CD5-positive hairy cell leukemia: a rare but distinct variant.Mod Pathol. 2009; 22: 258A
- Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics.Am J Clin Pathol. 2009; 131: 586-595
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Blood. 2016; 127: 2375-2390
- Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?.Br J Haematol. 2010; 150: 113-116
- Hairy cell leukemia variant: fact or fiction.Am J Clin Pathol. 2005; 123: 132-138
- The natural history and clinico-pathological features of the variant form of hairy cell leukemia.Leukemia. 2001; 15: 184-186
- A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients.Blood. 1990; 76: 157-162
- Phenotypic analysis of hairy cell leukemia: “variant” cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25).Blood. 1993; 82: 528-535
- Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).Hematol Oncol. 2011; 29: 47-51
- Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?.Blood. 2008; 111: 2253-2260
- Critical analysis and diagnostic usefulness of limited immunophenotyping of B-cell non-Hodgkin lymphomas by flow cytometry.Am J Clin Pathol. 2001; 115: 136-142
- CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.Arch Pathol Lab Med. 1998; 122: 539-544
- Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry.Am J Clin Pathol. 1999; 112: 319-329
- Mantle cell lymphoma with aberrant expression of CD10.Histopathology. 2008; 53: 20-29
- CD5- mantle cell lymphoma.Am J Clin Pathol. 2002; 118: 216-224
- CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.Am J Clin Pathol. 1999; 111: 123-130
- Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples.Am J Clin Pathol. 2002; 118: 758-764
- Discrepancies in the immunophenotype of lymphoma cells in samples obtained simultaneously from different anatomic sites.Am J Clin Pathol. 2002; 117: 644-650
- Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.Am J Clin Pathol. 2002; 117: 615-620
- Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.Blood. 1999; 94: 1848-1854
- Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.Blood. 1999; 94: 1840-1847
- CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.Blood. 2002; 99: 1023-1029
- Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.Blood. 2002; 100: 1177-1184
- Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.Br J Haematol. 2001; 115: 854-861
- The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.Blood. 2003; 101: 1262-1269
- V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.Blood. 2002; 100: 1410-1416
- CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.Blood. 2001; 98: 181-186
- Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.Blood. 2008; 112: 1923-1930
- CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.Leukemia. 2002; 16: 30-35
- Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.Leukemia. 2005; 19: 750-758
- CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.Cytometry B Clin Cytom. 2006; 70: 136-141
- Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.Br J Haematol. 2002; 118: 755-761
- CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.Hematol J. 2004; 5: 145-151
- Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.Cancer. 2005; 104: 2124-2132
- CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.Br J Haematol. 2002; 116: 142-150
- CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment.Blood. 2008; 111: 5173-5181
- Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.J Exp Med. 2001; 194: 1639-1647
- ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.N Engl J Med. 2003; 348: 1764-1775
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.Blood. 2003; 101: 4944-4951
- ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.Lancet. 2004; 363: 105-111
- A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.Am J Clin Pathol. 2010; 133: 708-717
- ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.N Engl J Med. 2004; 351: 893-901
- ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.Leukemia. 2003; 17: 2426-2434
- Flow cytometric detection of ZAP-70 in chronic lymphocytic leukemia: correlation with immunocytochemistry and Western blot analysis.Arch Pathol Lab Med. 2007; 131: 50-56
- Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia.Am J Clin Pathol. 2007; 127: 182-191
- Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory.Clin Lab Haematol. 2005; 27: 258-266
- ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.Cytometry B Clin Cytom. 2006; 70: 284-292
- Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied.Cytometry B Clin Cytom. 2006; 70: 242-250
- A standardized ZAP-70 assay–lessons learned in the trenches.Cytometry B Clin Cytom. 2006; 70: 276-283
- Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: a multicentric international harmonization process.Cytometry B Clin Cytom. 2006; 70: 309-314
- A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL).Cytometry B Clin Cytom. 2006; 70: 227-234
- ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis.Cytometry B Clin Cytom. 2006; 70: 235-241
- Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: comparison with IgV(H) mutation analysis.Cytometry B Clin Cytom. 2006; 70: 270-275
- Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.Blood. 2008; 111: 865-873
- Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.Br J Haematol. 2008; 142: 202-215
- CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.Br J Haematol. 2016; 172: 48-55
- CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.Leukemia. 2016; 30: 2011-2018
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.Br J Haematol. 2008; 140: 537-546
- CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.Cytometry B Clin Cytom. 2016; ([Epub ahead of print])
- CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance.Leukemia. 2006; 20 ([author reply: 528–9]): 523-525
- CD23 expression in follicular lymphoma: clinicopathologic correlations.Am J Clin Pathol. 2011; 135: 46-53
- CD38 in hairy cell leukemia is a marker of poor prognosis and a new target for therapy.Cancer Res. 2015; 75: 3902-3911
- Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.Leukemia. 2013; 27: 142-149
- Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL.Blood. 2014; 123: 3727-3732
- Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene.Am J Clin Pathol. 2003; 119: 213-217
- Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study.Haematologica. 2016; 101: 336-345
- Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.Blood. 2013; 122: 3759-3766
- Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone.Blood. 2003; 102: 2994-3002
- Immunophenotyping large B-cell lymphomas. Flow cytometric pitfalls and pathologic correlation.Am J Clin Pathol. 2001; 116: 191-203
- Most diffuse large B-cell lymphomas are identified by flow cytometry.Mod Pathol. 2012; 24: 339A
- Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival.Blood. 2009; 113: 3773-3780
- Diffuse large B cell lymphoma without immunoglobulin light chain restriction by flow cytometry.Acta Haematol. 2009; 121: 196-201
- CD200 in high-grade lymphoma, chronic lymphocytic leukemia, and chronic lymphocytic leukemia-phenotype monoclonal B-cell lymphocytosis.Am J Clin Pathol. 2015; 144: 677-679
- Swerdlow S.H. Campo E. Harris N.L. WHO classification of tumors of haematopoietic and lymphoid tissues. IARC, Lyon (France)2008
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.Blood. 2004; 103: 275-282
- Comparison of multiparameter flow cytometry with cluster analysis and immunohistochemistry for the detection of CD10 in diffuse large B-cell lymphomas.Mod Pathol. 2002; 15: 413-419
- De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.Blood. 2002; 99: 815-821
- Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.Am J Clin Pathol. 2001; 115: 385-395
- A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma.Am J Clin Pathol. 2010; 133: 718-726
- Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system.Am J Clin Pathol. 2012; 137: 665-670
- Bright CD38 expression is an indicator of MYC rearrangement.Leuk Lymphoma. 2009; 50: 1054-1057
- Flow cytometric comparison of Burkitt and CD10(+) large B-cell lymphomas [Abstract].Mod Pathol. 2005; 18: 237A
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.Blood. 2013; 121: 2253-2263
- Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.Blood. 2009; 114: 2273-2279
- The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.Haematologica. 2007; 92: 1335-1342
- Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.Haematologica. 2009; 94: 935-943
- Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis.Mod Pathol. 2006; 19: 25-33
- B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.Am J Surg Pathol. 2010; 34: 327-340
- Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.J Clin Oncol. 2012; 30: 3460-3467
- The unique immunophenotype of double-hit lymphomas.Am J Clin Pathol. 2011; 135: 649-650
- “Double-Hit” mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression.Am J Clin Pathol. 2010; 134: 258-265
- Flow cytometric evaluation of double/triple hit lymphoma.Oncol Res. 2016; 23: 137-146
- AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia.Cytometry B Clin Cytom. 2017; ([Epub ahead of print])
- The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?.Cytometry B Clin Cytom. 2014; 86: 329-339
- Flow cytometry in the diagnosis of acute leukemias and myelodysplastic/myeloproliferative disorders.in: Keren D.F. McCoy J.P. Carey J.L. Flow cytometry in clinical diagnosis. ASCP Press, Chicago2007: 151-198
- Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.Am J Clin Pathol. 2009; 132: 940-949
- Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience.Am J Clin Pathol. 2007; 127: 1-8
- Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.Cytometry B Clin Cytom. 2005; 68: 18-24
- Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection.Leukemia. 2005; 19: 49-56
- Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry.Blood. 2001; 98: 2498-2507
- Immunophenoytpic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry.Leuk Lymphoma. 2004; 45: 277-285
- Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors (“hematogones”) and B lymphoblastic leukemia blasts.Am J Clin Pathol. 2009; 132: 573-580
- Flow cytometric analysis of BCL-2 can distinguish small numbers of acute lymphoblastic leukaemia cells from B-cell precursors.Br J Haematol. 2004; 127: 50-58
- CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemia.Am J Clin Pathol. 2005; 123: 119-124
- Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.Am J Clin Pathol. 2009; 132: 692-698
- Antigen expression patterns reflecting genotype of acute leukemias.Leukemia. 2002; 16: 1233-1258
- Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia.Haematologica. 2009; 94: 1016-1019
- Reappraisal of the clinical and biologic significance of myeloid- associated antigen expression in childhood acute lymphoblastic leukemia.J Clin Oncol. 1998; 16: 3768-3773
- A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol.Blood. 2005; 105: 3434-3441
- Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study.Leukemia. 1998; 12: 1764-1770
- Marginal zone B-cell lymphoma: a retrospective immunophenotypic analysis.Cytometry B Clin Cytom. 2008; 74: 282-286
- Lymphoplasmacytoid lymphoma: an immunophenotypic re-evaluation.Mod Pathol. 2001; 14 ([abstract]): 157A
- Diagnostic usefulness of CD23 and FMC-7 antigen expression patterns in B-cell lymphoma classification.Am J Clin Pathol. 2001; 115: 258-265
- Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.Blood. 2000; 95: 1950-1956
- The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders.Blood. 1994; 83: 1558-1562
- Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.Am J Clin Pathol. 2003; 120: 754-759
- The immunophenotype of prolymphocytoid transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) revisited.Mod Pathol. 2013; 26: 356A-357A
- Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia.Am J Clin Pathol. 1996; 106: 457-461
- Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).Cytometry B Clin Cytom. 2003; 56: 30-42
- CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype.Arch Pathol Lab Med. 2003; 127: 561-566
Article info
Publication history
Published online: August 30, 2017
Footnotes
The authors have nothing to disclose.
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
